News & Events about Resmed Inc.
ResMed Inc. (NYSE:RMD Get Rating) COO Robert Andrew Douglas sold 1,500 shares of ResMed stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $224.65, for a total transaction of $336,975.00. Following the completion of the sale, the chief ...
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 shares ...
Ticker Report
2 months ago
ResMed Inc. (NYSE:RMD Get Rating) CEO Michael J. Farrell sold 5,675 shares of the stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $206.95, for a total transaction of $1,174,441.25. Following the sale, the chief executive officer now owns 436,900 ...
Globe Newswire
2 months ago
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, beginning at approximately 11:20 a.m. (Eastern Daylight Time) ...